Diabetes often ranks as the top trend driver, accounting for a quarter of pharmacy spend
Between early 2022 and mid-2024, more than 6 million patients were identified with a type 2 diabetes diagnosis
GLP-1 user insights: overview Health and side-effects are driving choices Smaller, smarter consumption preference is for bite-sized formats, smaller portions and clearer in-store guidance Overall grocery spend down by 780m Trend set to grow cost is a barrier today, but cheaper GLP-1 pills could accelerate adoption further GLP-1 take-up in Europe has been slower than the US, but its speeding up
However, the effects of whitening pills vary from person to person, so it's best to consult a doctor or professional beautician before deciding to use them
Think of a small, empty sphere made from phospholipidsthe same components as your cell membranes